trial

Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1

NCTId NCT00046813
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Terminated
Enrollment 100
Sponsored by National Institute on Drug Abuse (NIDA)
Primary completion 2005-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Terminated
Enrollment
100
Study type
Interventional
Allocation
—
Model
—
Masking
Double
Start
2001-08
Primary completion
2005-04
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
Nicotine patch

Sponsors

National Institute on Drug Abuse (NIDA)Lead Sponsor

Investigators

1
Jill M. Williams, M.D.Principal Investigator

Sites

2 total
Piscataway, United StatesPiscataway, United States

Facts & assertions

4 sourced
Enrollment
100
Phase
PHASE4
Primary Completion Date
2005-04
Status
TERMINATED
relationships
The graph out of here
drug
Nicotine patch
drug
lead_sponsor
National Institute on Drug Abuse (NIDA)
company
indication
Tobacco Use Disorder
indication
Tobacco Use Disorder
indication
investigator
Jill M. Williams, M.D.
person